Pathophysiology of cardiovascular structural changes in hypertension

S Jern1

  • 1Department of Clinical Physiology, Ostra Hospital, University of Göteborg, Sweden.

Insights

Essential hypertension causes left ventricular hypertrophy and vascular changes, increasing cardiovascular risks. These structural changes in the heart and blood vessels develop together and are linked to genetic and hemodynamic factors.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Vascular Biology

Background:

  • Essential hypertension is characterized by left ventricular hypertrophy and vascular remodeling.
  • Left ventricular hypertrophy in hypertensive patients significantly elevates the risk of cardiovascular complications, independent of other risk factors.
  • These cardiac and vascular structural changes occur in parallel, even in early stages of hypertension.

Purpose of the Study:

  • To elucidate the relationship between left ventricular hypertrophy and peripheral vascular changes in essential hypertension.
  • To understand the timing of structural changes in relation to hypertension.
  • To explore the underlying pathophysiological mechanisms driving these structural adaptations.

Main Methods:

  • Review of existing evidence on hypertensive cardiovascular and vascular remodeling.
  • Analysis of studies detecting structural changes in early-phase hypertension.
  • Examination of the interplay between genetic, hemodynamic, and humoral-metabolic factors in hypertension pathophysiology.

Main Results:

  • Left ventricular hypertrophy and vascular structural changes are prominent features of established essential hypertension.
  • The risk of hypertensive cardiovascular complications increases with left ventricular hypertrophy.
  • Structural alterations in both the left ventricle and peripheral vasculature are detectable early in borderline hypertension and develop concurrently.

Conclusions:

  • Left ventricular hypertrophy and vascular remodeling are key adaptations in essential hypertension.
  • These structural changes contribute significantly to cardiovascular risk.
  • The development of these changes is multifactorial, involving genetic, hemodynamic, and humoral-metabolic influences.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...